Anavex Life Sciences Corp (AVXL)
SG&A Expense Growth
4.06%
Quarterly · Period ending:
AVXL SG&A Expense Growth
Latest reported4.06%period ending
Latest reported4.06%period ending
AVXL Quarterly SG&A Growth (QoQ) (0.00% → 4.06%)
Latest values, visible window
High-resolution chart · PNG
AVXL sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 4.0576% | |
| 7.8081% | |
| -40.1127% | |
| -21.1111% | |
| 71.6902% | |
| -16.6879% | |
| 13.1248% | |
| -0.394% | |
| -3.5579% | |
| 7.461% | |
| 3.9531% | |
| -20.2108% | |
| 12.6604% | |
| -13.0841% | |
| -15.0034% | |
| 22.5104% | |
| 9.272% | |
| -4.9493% | |
| 6.529% | |
| 18.2758% | |
| 8.9707% | |
| 51.8877% | |
| 4.8256% | |
| 1.5547% | |
| -19.6882% | |
| 27.2261% | |
| -17.3225% | |
| 17.756% | |
| -32.6269% | |
| 17.0296% | |
| 18.8837% | |
| -8.5684% | |
| 8.7904% | |
| 6.5565% | |
| 2.7003% | |
| -3.1298% | |
| 25.8968% | |
| -0.903% | |
| -49.8114% | |
| 97.7279% | |
| 4.1485% | |
| -67.6545% | |
| 4.6121% | |
| 351.3305% | |
| 58.1359% | |
| -0.1902% | |
| 53.0728% | |
| -59.7558% | |
| -18.7369% | |
| 196.6268% | |
| -77.7571% | |
| 1,473.8722% | |
| -31.2838% | |
| -56.0448% | |
| -45.4679% | |
| 74.8699% | |
| -17.1893% | |
| -22.1794% | |
| -25.898% | |
| -26.1464% | |
| -29.5612% | |
| 39.802% | |
| -0.3785% | |
| 26.819% | |
| -1.9446% | |
| 4.9989% | |
| -8.4303% | |
| -8.9009% | |
| 81.6449% | |
| -29.0505% | |
| -61.1495% | |
| 47.3553% | |
| 149.008% | |
| -37.012% | |
| 178.2752% | |
| 16.2708% | |
| 49.3843% | |
| 1,072.9446% | |
| 113.1239% | |
| 0.898% | |
| 21.867% | |
| -50.4624% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |